$JPM

Autonomous Research Adjusts PT on JPMorgan Chase to $354 From $352, Keeps Neutral Rating

Autonomous Research raised its price target on JPMorgan Chase to $354 from $352, maintaining a neutral rating. The adjustment comes as major banks prepare to report earnings in a rising yield environment, according to UBS.

Original reporting
Published Oct 6, 2026, 10:55 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 12:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$JPM
Bullish
high confidence
Mentioned
$JPM
Relevance
7/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$JPMBullishMed
01

Why it matters

The price target lift signals a slightly more favorable outlook, which may influence short-term trading decisions.

02

Market read

A modest PT increase for a large-cap bank could prompt short-term buying pressure.

03

What to watch

Potential macro headwinds or credit concerns could offset the positive impact.

Relevance 7/10Novelty 6/10Timing: pre-market today

Background

Autonomous Research provides equity research coverage on JPMorgan Chase, adjusting valuation assumptions.

Company-level read

Ticker impact

$JPMBullishHigh confidence
Context

Autonomous Research raised JPMorgan Chase's price target to $354 from $352.

Expected impact

likely upward pressure as investors price in the higher target

Evidence & confidence

The new target reflects a modestly more optimistic valuation, which can attract buying.

Market effects

May slightly boost banking sector sentiment as a major bank receives a higher target.

U.S. financial stocks could see modest gains.

Limited to investors tracking large-cap U.S. banks.

Counterpoint

The target increase is modest; price may already reflect the new view, limiting upside.

Key entities

  • Autonomous Research

    Equity research provider issuing the price target update.

  • JPMorgan Chase & Co.

    U.S. multinational bank and the subject of the price target change.

Related articles

$JPMHighAI 8/10

JPMorgan Chase: Barclays Reiterates Overweight Rating

Barclays reiterated its Overweight rating on JPMorgan Chase (JPM). The bank reported Q2 2026 net income of $21.2B and EPS of $7.70, with adjusted figures of $16.9B and $6.14. Barclays advises evaluating JPMorgan's recurring profitability, deposit pricing, and fee income sustainability.

$SOFIMed

Institutional Stablecoin Settlement Just Went From Zero to Four Production Rails in a Single Month

Stablecoin settlement volume grew significantly in September 2026, with $1.2B spent on stablecoin-linked cards. SoFi and Mastercard launched SoFiUSD for card settlements, migrating $25B annualized volume. Visa's stablecoin settlement reached $20B annualized, a 15x increase. Stripe expanded stablecoin card programs to 100+ countries. Solana launched a DvP standard for faster, cheaper settlements.

$JPMMed

JPMorgan Stock Is Up Just 3% This Year as Its Multiple Shrank. Here’s What Doug Petno’s Q3 Guidance Says About the Gap

JPMorgan Chase (JPM) stock is up 3.2% YTD, trading at $332.38. Analysts expect ~$24 EPS over the next 12 months, reducing its forward P/E to ~14x. BofA and UBS cut price targets to $400 and $395, respectively, both maintaining Buy ratings. JPMorgan's Q3 results are due October 13, with guidance from CEO Doug Petno suggesting mid- to high-teens growth in investment banking fees and Markets revenue.

$AAPLMed

ICE, OKX venture plans trading of tokenized US stocks via Uniswap pools

OKXICE, a joint venture between Intercontinental Exchange and OKX, plans to trade tokenized US stocks via Uniswap pools on OKX's blockchain. The SEC exemption allows trading of over 60 stocks, including Apple, Nvidia, and Tesla, against stablecoins. Trading could start in early November, pending a 30-day waiting period. OKXICE controls the pools and trading permissions. Cerebras has objected to their stock being included.